Clabaut M, Cougnaud A, Schrub J C
J Pharmacol. 1982 Apr-Jun;13(2):253-63.
Female rats rendered diabetics following administration of streptozotocin (40 mg/kg/day I.V.) on the fifth day of pregnancy received daily injections of nicergolin) 200 micrograms/kg/day or 400 micrograms/kg/day I.P.) from day 5 through day 19 of gestation, when animals were sacrificed. It was found that nicergoline significantly reduces the frequency of abortions increases the weight of foetuses and placentas when compared to control diabetic rats. These effects are due neither to a maternal or foetal reduction of glycemia nor to modifications of insulinemia or the levels of sexual hormones of the mother. Histopathological examination of the placentas confirms the positive effect of nicergolin and appears to be due to a direct vascular action.
在妊娠第5天静脉注射链脲佐菌素(40毫克/千克/天)制成糖尿病模型的雌性大鼠,从妊娠第5天至第19天每天腹腔注射尼麦角林(200微克/千克/天或400微克/千克/天),之后处死动物。结果发现,与对照糖尿病大鼠相比,尼麦角林可显著降低流产频率,增加胎儿和胎盘重量。这些作用既不是由于母体或胎儿血糖降低,也不是由于胰岛素血症或母体性激素水平的改变。胎盘的组织病理学检查证实了尼麦角林的积极作用,这似乎是由于直接的血管作用。